WO1998040097A3 - Coronavirus respiratoire bovin utilise comme vaccin - Google Patents
Coronavirus respiratoire bovin utilise comme vaccin Download PDFInfo
- Publication number
- WO1998040097A3 WO1998040097A3 PCT/US1998/004392 US9804392W WO9840097A3 WO 1998040097 A3 WO1998040097 A3 WO 1998040097A3 US 9804392 W US9804392 W US 9804392W WO 9840097 A3 WO9840097 A3 WO 9840097A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vaccine
- bovine respiratory
- bovine
- coronavirus
- enteric coronavirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ337702A NZ337702A (en) | 1997-03-10 | 1998-03-04 | Bovine respiratory coronavirus (BRCV) or bovine enteric coronavirus (BECV) as a vaccine for protecting against diseases caused by both BECV and BRCV |
DE1998635424 DE69835424T2 (de) | 1997-03-10 | 1998-03-04 | Boviner atmungs- und darmcoronavirus als impfstoff |
AU63465/98A AU725439B2 (en) | 1997-03-10 | 1998-03-04 | Bovine respiratory coronavirus as a vaccine |
KR10-1999-7007847A KR100531491B1 (ko) | 1997-03-10 | 1998-03-04 | 백신으로서 소 호흡 코로나바이러스 |
EP98907727A EP0975360B1 (fr) | 1997-03-10 | 1998-03-04 | Coronavirus respiratoire bovin utilise comme vaccin |
BR9808226A BR9808226A (pt) | 1997-03-10 | 1998-03-04 | Coronavìrus respiratório bovino como uma vacina |
JP53963698A JP2001519781A (ja) | 1997-03-10 | 1998-03-04 | ワクチンとしてのウシの呼吸器および腸コロナウイルス |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81431197A | 1997-03-10 | 1997-03-10 | |
US08/814,311 | 1997-03-10 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1998040097A2 WO1998040097A2 (fr) | 1998-09-17 |
WO1998040097A3 true WO1998040097A3 (fr) | 1999-01-14 |
WO1998040097A9 WO1998040097A9 (fr) | 1999-02-25 |
Family
ID=25214684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/004392 WO1998040097A2 (fr) | 1997-03-10 | 1998-03-04 | Coronavirus respiratoire bovin utilise comme vaccin |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0975360B1 (fr) |
JP (1) | JP2001519781A (fr) |
KR (1) | KR100531491B1 (fr) |
CN (1) | CN1283315C (fr) |
AT (1) | ATE334697T1 (fr) |
AU (1) | AU725439B2 (fr) |
BR (1) | BR9808226A (fr) |
CA (1) | CA2231591A1 (fr) |
DE (1) | DE69835424T2 (fr) |
DK (1) | DK0975360T3 (fr) |
ES (1) | ES2270508T3 (fr) |
NZ (1) | NZ337702A (fr) |
WO (1) | WO1998040097A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0000891D0 (en) * | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
CN100438908C (zh) * | 2001-10-06 | 2008-12-03 | 梅瑞尔有限公司 | CpG制剂及相关方法 |
US7375202B2 (en) * | 2003-03-24 | 2008-05-20 | The University Of Hong Kong | Human virus causing severe acute respiratory syndrome (SARS) and uses thereof |
WO2005005596A2 (fr) * | 2003-06-18 | 2005-01-20 | Chinese National Human Genome Center At Shanghai | Caracterisation des stades les plus precoces du virus du syndrome respiratoire aigu severe (sras), et applications |
CN1318580C (zh) * | 2003-07-10 | 2007-05-30 | 北京科兴生物制品有限公司 | 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法 |
WO2011056175A1 (fr) | 2009-11-06 | 2011-05-12 | Intervet International B.V. | Méthodes d'immunisation de génisses gravides à trois mois de gestation |
AU2015310932B2 (en) * | 2014-09-03 | 2018-11-22 | Intervet International B.V. | Attenuated bovine coronavirus and related vaccines |
CN111117975A (zh) * | 2020-01-03 | 2020-05-08 | 西南民族大学 | 牛冠状病毒he基因重组株及其制备的灭活疫苗和应用 |
CN113322241B (zh) * | 2021-05-14 | 2023-06-13 | 金宇保灵生物药品有限公司 | 一种牛副流感病毒3型病毒株bpiv3-nm及其应用 |
CN117286111B (zh) * | 2023-03-13 | 2024-06-18 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | 牛冠状病毒分离株、稳定表达牛冠状病毒n蛋白细胞系及在构建反向遗传操作系统中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995034686A1 (fr) * | 1994-06-15 | 1995-12-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Isolation et diagnostic de coronavirus |
WO1996041874A1 (fr) * | 1995-06-12 | 1996-12-27 | Kansas State University Research Foundation | Nouveau vaccin multivalent a base de virus corona bovin et methode de traitement de l'infection au virus corona bovin |
-
1998
- 1998-03-04 WO PCT/US1998/004392 patent/WO1998040097A2/fr active IP Right Grant
- 1998-03-04 BR BR9808226A patent/BR9808226A/pt not_active Application Discontinuation
- 1998-03-04 DE DE1998635424 patent/DE69835424T2/de not_active Expired - Fee Related
- 1998-03-04 KR KR10-1999-7007847A patent/KR100531491B1/ko not_active IP Right Cessation
- 1998-03-04 AU AU63465/98A patent/AU725439B2/en not_active Ceased
- 1998-03-04 EP EP98907727A patent/EP0975360B1/fr not_active Expired - Lifetime
- 1998-03-04 NZ NZ337702A patent/NZ337702A/en unknown
- 1998-03-04 CN CNB988032457A patent/CN1283315C/zh not_active Expired - Fee Related
- 1998-03-04 DK DK98907727T patent/DK0975360T3/da active
- 1998-03-04 JP JP53963698A patent/JP2001519781A/ja not_active Withdrawn
- 1998-03-04 ES ES98907727T patent/ES2270508T3/es not_active Expired - Lifetime
- 1998-03-04 AT AT98907727T patent/ATE334697T1/de not_active IP Right Cessation
- 1998-03-09 CA CA 2231591 patent/CA2231591A1/fr not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995034686A1 (fr) * | 1994-06-15 | 1995-12-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Isolation et diagnostic de coronavirus |
WO1996041874A1 (fr) * | 1995-06-12 | 1996-12-27 | Kansas State University Research Foundation | Nouveau vaccin multivalent a base de virus corona bovin et methode de traitement de l'infection au virus corona bovin |
Non-Patent Citations (5)
Title |
---|
C. MEBUS ET AL.: "Neonatal calf diarrhea: propagation, attenuation, and characteristics of a coronavirus-like agent.", AMERICAN JOURNAL OF VETERINARY RESEARCH, vol. 34, no. 2, 1973, Schaumburg, USA, pages 145 - 150, XP002084560 * |
E. THURBER ET AL.: "Field trial evaluation of a reo-coronavirus calf diarrhea vaccine.", CANADIAN JOURNAL OF COMPARATIVE MEDICINE, vol. 41, no. 2, April 1977 (1977-04-01), Ottawa, Canada, pages 131 - 136, XP002084558 * |
J. STORZ ET AL.: "Coronavirus isolation from nasal swap samples in cattle with signs of respiratory-tract disease after shipping.", JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, vol. 208, no. 9, 1 May 1996 (1996-05-01), Chicago, IL, USA, pages 1452 - 1455, XP002084556 * |
K. MÖSTL ET AL.: "Incidence of diarrhoea and of rotavirus- and coronavirus-shedding in calves, whose dams had been vaccinated with an experimental oil-adjuvanted vaccine containing bovine rotavirus and bovine coronavirus.", JOURNAL OF VETERINARY MEDICINE, vol. 35, no. 3, April 1988 (1988-04-01), Hamburg, Germany, pages 186 - 196, XP002084557 * |
L. MYERS ET AL.: "Colostral and milk antibody titers in cows vaccinated with a modified live-rotavirus-coronavirus vaccine.", JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, vol. 181, no. 5, 1 September 1982 (1982-09-01), Chicago, IL, USA, pages 486 - 488, XP002084559 * |
Also Published As
Publication number | Publication date |
---|---|
AU6346598A (en) | 1998-09-29 |
DE69835424T2 (de) | 2007-02-08 |
CA2231591A1 (fr) | 1998-09-10 |
ATE334697T1 (de) | 2006-08-15 |
WO1998040097A2 (fr) | 1998-09-17 |
CN1250380A (zh) | 2000-04-12 |
KR100531491B1 (ko) | 2005-11-28 |
NZ337702A (en) | 2001-05-25 |
ES2270508T3 (es) | 2007-04-01 |
KR20000075775A (ko) | 2000-12-26 |
AU725439B2 (en) | 2000-10-12 |
BR9808226A (pt) | 2000-05-16 |
CN1283315C (zh) | 2006-11-08 |
EP0975360A2 (fr) | 2000-02-02 |
DE69835424D1 (de) | 2006-09-14 |
DK0975360T3 (da) | 2006-11-27 |
JP2001519781A (ja) | 2001-10-23 |
EP0975360B1 (fr) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2322801B (en) | Vaccine compositions for intranasal administration comprising chitosan and use thereof | |
ES2140076T3 (es) | Vacunas que contienen una saponina y un esterol. | |
MX9604907A (es) | Vacuna de combinacion de virus para la enfermedad de newcastle. | |
TR200002855T2 (tr) | Raloksifenin solunum yolu ile veya burundan uygulanması. | |
FI964681A (fi) | Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt | |
BG104511A (en) | Spheroids, preparation method and pharmaceutical compositions | |
DE60210456D1 (de) | Solubisierung von kapseln polysacchariden | |
SE9704546D0 (sv) | Novel compounds | |
WO1998040097A3 (fr) | Coronavirus respiratoire bovin utilise comme vaccin | |
AU2001258373A1 (en) | Method for identifying helicobacter antigens | |
AP9901666A0 (en) | Leishmania vaccine. | |
WO1999057278A3 (fr) | Immunisation et traitement anti-infectieux | |
ES2184987T3 (es) | Formas de administracion solidas de liberacion instantanea y procedimiento para su preparacion. | |
IL141443A0 (en) | Vaccine comprising cytokine-induced heat shock proteins (hsp) | |
WO1999020305A8 (fr) | Vaccins veterinaires | |
AP9801399A0 (en) | Zona pellucida proteins for contraception. | |
PT796256E (pt) | Novos processos de preparacao da ranitidina | |
MD1473G2 (ro) | Remediu antiherpetic | |
AU7728296A (en) | Hemoregulatory compounds | |
ECSP961731A (es) | Vacunas | |
UA23872A (uk) | Лікувальний препарат (його варіанти) | |
UA49450A (uk) | Вакцина інактивована рекомбінантна проти інфекційного ринотрахеїту великої рогатої худоби | |
UA18990A (uk) | Зубhий імплаhтат |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98803245.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 4, 6, 8, 11 AND 12, DESCRIPTION, REPLACED BY NEW PAGES 4, 6, 8, 11 AND 12; PAGES 31 AND 32, CLAIMS, REPLACED BY NEW PAGES 31 AND 32; AFTER RECTIFICATION OF OBVIOUS ERRORS AS AUTHORIZED BY THE INTERNATIONAL SEARCHING AUTHORITY |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998907727 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997007847 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 1998 539636 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 63465/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 337702 Country of ref document: NZ |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1998907727 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997007847 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 63465/98 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019997007847 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998907727 Country of ref document: EP |